199 related articles for article (PubMed ID: 10200249)
21. Insights into the interaction of discodermolide and docetaxel with tubulin. Mapping the binding sites of microtubule-stabilizing agents by using an integrated NMR and computational approach.
Canales A; Rodríguez-Salarichs J; Trigili C; Nieto L; Coderch C; Andreu JM; Paterson I; Jiménez-Barbero J; Díaz JF
ACS Chem Biol; 2011 Aug; 6(8):789-99. PubMed ID: 21539341
[TBL] [Abstract][Full Text] [Related]
22. A quantitative evaluation of the effects of inhibitors of tubulin assembly on polymerization induced by discodermolide, epothilone B, and paclitaxel.
Dabydeen DA; Florence GJ; Paterson I; Hamel E
Cancer Chemother Pharmacol; 2004 May; 53(5):397-403. PubMed ID: 15060743
[TBL] [Abstract][Full Text] [Related]
23. Simplified discodermolide analogues: synthesis and biological evaluation of 4-epi-7-dehydroxy-14,16-didemethyl-(+)-discodermolides as microtubule-stabilizing agents.
Choy N; Shin Y; Nguyen PQ; Curran DP; Balachandran R; Madiraju C; Day BW
J Med Chem; 2003 Jul; 46(14):2846-64. PubMed ID: 12825928
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of natural product microtubule stabilizers on microtubule assembly: single agent and combination studies with taxol, epothilone B, and discodermolide.
Gertsch J; Meier S; Müller M; Altmann KH
Chembiochem; 2009 Jan; 10(1):166-75. PubMed ID: 19058273
[TBL] [Abstract][Full Text] [Related]
25. A unified and quantitative receptor model for the microtubule binding of paclitaxel and epothilone.
Wang M; Xia X; Kim Y; Hwang D; Jansen JM; Botta M; Liotta DC; Snyder JP
Org Lett; 1999 Jul; 1(1):43-6. PubMed ID: 10822530
[TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of (+)-discodermolide-paclitaxel hybrids leading to enhanced biological activity.
Smith AB; Sugasawa K; Atasoylu O; Yang CP; Horwitz SB
J Med Chem; 2011 Sep; 54(18):6319-27. PubMed ID: 21870795
[TBL] [Abstract][Full Text] [Related]
27. Structure-activity relationship studies of discodermolide and its semisynthetic acetylated analogs on microtubule function and cytotoxicity.
Isbrucker RA; Gunasekera SP; Longley RE
Cancer Chemother Pharmacol; 2001 Jul; 48(1):29-36. PubMed ID: 11488521
[TBL] [Abstract][Full Text] [Related]
28. Cell-based and biochemical structure-activity analyses of analogs of the microtubule stabilizer dictyostatin.
Raccor BS; Vogt A; Sikorski RP; Madiraju C; Balachandran R; Montgomery K; Shin Y; Fukui Y; Jung WH; Curran DP; Day BW
Mol Pharmacol; 2008 Mar; 73(3):718-26. PubMed ID: 18073274
[TBL] [Abstract][Full Text] [Related]
29. Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action.
Bollag DM; McQueney PA; Zhu J; Hensens O; Koupal L; Liesch J; Goetz M; Lazarides E; Woods CM
Cancer Res; 1995 Jun; 55(11):2325-33. PubMed ID: 7757983
[TBL] [Abstract][Full Text] [Related]
30. Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs.
Chen JG; Horwitz SB
Cancer Res; 2002 Apr; 62(7):1935-8. PubMed ID: 11929805
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and biological evaluation of a simplified fluorescently labeled discodermolide as a molecular probe to study the binding of discodermolide to tubulin.
Qi J; Blanden AR; Bane S; Kingston DG
Bioorg Med Chem; 2011 Sep; 19(17):5247-54. PubMed ID: 21802957
[TBL] [Abstract][Full Text] [Related]
32. Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin.
Madiraju C; Edler MC; Hamel E; Raccor BS; Balachandran R; Zhu G; Giuliano KA; Vogt A; Shin Y; Fournier JH; Fukui Y; Brückner AM; Curran DP; Day BW
Biochemistry; 2005 Nov; 44(45):15053-63. PubMed ID: 16274252
[TBL] [Abstract][Full Text] [Related]
33. Strategies for the development of novel Taxol-like agents.
Mooberry SL
Methods Mol Med; 2007; 137():289-302. PubMed ID: 18085237
[TBL] [Abstract][Full Text] [Related]
34. Acetylated analogues of the microtubule-stabilizing agent discodermolide: preparation and biological activity.
Gunasekera SP; Longley RE; Isbrucker RA
J Nat Prod; 2001 Feb; 64(2):171-4. PubMed ID: 11429994
[TBL] [Abstract][Full Text] [Related]
35. Synthetic chemistry. Cancer drugs better than taxol?
Cowden CJ; Paterson I
Nature; 1997 May; 387(6630):238-9. PubMed ID: 9153384
[No Abstract] [Full Text] [Related]
36. Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol).
Long BH; Carboni JM; Wasserman AJ; Cornell LA; Casazza AM; Jensen PR; Lindel T; Fenical W; Fairchild CR
Cancer Res; 1998 Mar; 58(6):1111-5. PubMed ID: 9515790
[TBL] [Abstract][Full Text] [Related]
37. The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity.
Pryor DE; O'Brate A; Bilcer G; Díaz JF; Wang Y; Wang Y; Kabaki M; Jung MK; Andreu JM; Ghosh AK; Giannakakou P; Hamel E
Biochemistry; 2002 Jul; 41(29):9109-15. PubMed ID: 12119025
[TBL] [Abstract][Full Text] [Related]
38. Structural Basis of Microtubule Stabilization by Discodermolide.
Prota AE; Bargsten K; Redondo-Horcajo M; Smith AB; Yang CH; McDaid HM; Paterson I; Horwitz SB; Fernando Díaz J; Steinmetz MO
Chembiochem; 2017 May; 18(10):905-909. PubMed ID: 28207984
[TBL] [Abstract][Full Text] [Related]
39. Microtubule structure at improved resolution.
Meurer-Grob P; Kasparian J; Wade RH
Biochemistry; 2001 Jul; 40(27):8000-8. PubMed ID: 11434769
[TBL] [Abstract][Full Text] [Related]
40. Semisynthetic analogues of the microtubule-stabilizing agent discodermolide: preparation and biological activity.
Gunasekera SP; Longley RE; Isbrucker RA
J Nat Prod; 2002 Dec; 65(12):1830-7. PubMed ID: 12502323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
